Enterprise Financial Services Corp (EFSC)’s Sarepta Therapeutics SRPT Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-38	Closed	-$3K	–	1095
2021 Q2	$3K	Sell	38 -51	-57%	-$3.87K	﹤0.01%	1074
2021 Q1	$7K	Buy	89 +84	+1,680%	+$7.75K	﹤0.01%	856
2020 Q4	$1K	Buy	+5	New	+$741	﹤0.01%	1251
2020 Q3	–	Sell	-8	Closed	-$1K	–	1306
2020 Q2	$1K	Sell	8 -2	-20%	-$272	﹤0.01%	1225
2020 Q1	$1K	Buy	+10	New	+$1.14K	﹤0.01%	1211
2016 Q1	–	Sell	-28	Closed	-$1K	–	1126
2015 Q4	$1K	Hold	28	–	–	﹤0.01%	1050
2015 Q3	$1K	Buy	+28	New	+$950	﹤0.01%	1019

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s SRPT Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Sarepta Therapeutics (SRPT) in Q3 2021, closing a stake of 38 shares — an estimated $3K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in SRPT in Q3 2015 and held it in 7 quarters. The position peaked at $7K in Q1 2021. 307 funds tracked by Wall St. Rank hold SRPT as of Q3 2021.

Enterprise Financial Services Corp (EFSC) reported no remaining Sarepta Therapeutics position as of Q3 2021 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 38 Sarepta Therapeutics shares in Q3 2021, an estimated $3K.
Enterprise Financial Services Corp (EFSC) first reported a position in Sarepta Therapeutics in Q3 2015 and held it in 7 quarters.
Enterprise Financial Services Corp (EFSC)'s Sarepta Therapeutics position peaked at $7K in Q1 2021.
307 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.